UNASSIGNED: This Guideline is an official statement of the European Society of Gastrointestinal Endoscopy (ESGE) and the European Society of Gastroenterology and Endoscopy Nurses and Associates (ESGENA). It addresses the administration of @entity1875 by non-anesthesiologists for @entity344 . Main Recommendations 1 We recommend that the type of endoscopic procedure and the @entity1 's American Society of Anesthesiologists (ASA) physical status, age, body mass index, Mallampati's classification, and risk factors for @entity27 ( @entity27 ) be assessed before each procedure with non-anesthesiologist administration of @entity1875 (NAAP) (strong recommendation, moderate quality evidence). 2 We suggest primary involvement of an anesthesiologist in @entity1 of ASA class >= 3, with a Mallampati's class >= 3 or other conditions that put them at risk of @entity1224 (e.g. @entity5 ), in @entity1 who chronically receive significant amounts of narcotic analgesics, or in cases where a long-lasting procedure is anticipated (weak recommendation, low quality evidence). 3 We suggest consideration of capnographic monitoring during NAAP in specific situations including high risk @entity1 , intended deep sedation, and long procedures (weak recommendation, high quality evidence). 4 We suggest @entity1875 monotherapy except in particular situations (weak recommendation, high quality evidence). 5 We recommend administering @entity1875 through intermittent bolus infusion or perfusor systems, including target-controlled infusion (TCI), and consideration of @entity1 -controlled sedation (PCS) in particular situations (strong recommendation, high quality evidence). 6 We suggest that @entity1 listen to self-selected music during upper and lower @entity344 (weak recommendation, moderate quality evidence). 7 We do not suggest using pharyngeal anesthesia during @entity1875 sedation for upper @entity344 (weak recommendation, moderate quality evidence). 8 We suggest using the post-anesthetic discharge scoring system (PADSS) to determine when @entity1 recovery is sufficient to allow discharge (weak recommendation, low quality evidence). 9 Minimum discharge criteria should be fulfilled before discharging a @entity1 . We recommend that @entity1 who have received combined regimens, and all @entity1 of ASA class >2, should upon discharge be accompanied by a responsible @entity1 and refrain for 24 hours from driving, drinking @entity285 , operating heavy machinery, or engaging in legally binding decisions. Advice should be provided verbally and in written form to the @entity1 , including a 24-hour contact phone number (strong recommendation, low quality evidence). 10 For @entity1 of ASA classes 1-2 who have received low dose @entity1875 monotherapy, a 6-hour limit is suggested (weak recommendation, low quality evidence).

Non-anesthesiologist administration of XXXX for gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy, European Society of Gastroenterology and Endoscopy Nurses and Associates Guideline - Updated June 2015.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient', 'person'] @entity5 :: ('MESH:D009369', 'Disease') :: ['pharyngolaryngeal tumors'] @entity27 :: ('MESH:D020181', 'Disease') :: ['obstructive sleep apnea', 'OSA'] @entity344 :: ('MESH:D005767', 'Disease') :: ['gastrointestinal (GI) endoscopy', 'GI endoscopy procedures', 'GI endoscopy'] @entity1875 :: ('MESH:D015742', 'Chemical') :: ['propofol'] @entity285 :: ('D000431', 'Chemical') :: ['alcohol'] @entity1224 :: ('MESH:D000402', 'Disease') :: ['airway obstruction']
@entity1875 :: (MESH:D015742,Chemical) :: ['propofol']
